STRATA Skin Sciences, Inc. Announces Compliance with Nasdaq Listing Rules
HORSHAM, Pa. , Nov. 19, 2019 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN) (“STRATA” or the “Company”), a medical technology company in Dermatology and Plastic Surgery dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic
STRATA Filed its Quarterly Reports for the First Three Quarters of 2019 on Form 10-Q
Company recurring revenue segment revenue up 13% for the nine months ended September 30, 2019 over comparable period in 2018 Company recurring revenue segment gross margins for the nine months ended September 30, 2019 and 2018 were 68.0% and 62.5%, respectively Company generated $1.6 million
STRATA Skin Sciences to Participate in the 13th Annual Canaccord Genuity Medical Technologies & Diagnostics Forum
HORSHAM, Pa. , Nov. 14, 2019 (GLOBE NEWSWIRE) -- STRATA Skin Sciences (NASDAQ: SSKN) (“STRATA”) a medical technology company in Dermatology and Plastic Surgery dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, today announced
STRATA Skin Sciences Receives Extension to Stay of Suspension from NASDAQ Listing
Company filed its Annual Report on Form 10-K for the year ended December 31, 2018 Management will host business update call on Wednesday, October 30th at 8:30 am ET HORSHAM, Pa. , Oct. 29, 2019 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN) (“STRATA” or the “Company”), a medical
Strata Skin Sciences Receives Nasdaq Notice of Non-compliance
HORSHAM, Pa. , Oct. 07, 2019 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (Nasdaq: SSKN) (“STRATA” or the “Company”), a medical technology company in Dermatology and Plastic Surgery dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic
STRATA Skin Sciences to Participate in Ladenburg Thalmann 2019 Healthcare Conference
HORSHAM, Pa. , Sept. 10, 2019 (GLOBE NEWSWIRE) -- STRATA Skin Sciences (NASDAQ: SSKN) (“STRATA”) a medical technology company in Dermatology and Plastic Surgery dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, today announced
STRATA Skin Sciences to Participate in H.C. Wainwright’s Annual Healthcare Conference
HORSHAM, Pa. , Aug. 28, 2019 (GLOBE NEWSWIRE) -- STRATA Skin Sciences (NASDAQ: SSKN) (“STRATA”) a medical technology company in Dermatology and Plastic Surgery dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, today announced
STRATA Skin Sciences Receives Notice of Filing Delinquency from NASDAQ
HORSHAM, Pa. , Aug. 16, 2019 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN) (“STRATA” or the “Company”), a medical technology company in Dermatology and Plastic Surgery dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic
STRATA Skin Sciences Announces Preliminary Second Quarter 2019 Financial Results and Updates
Unaudited Second Quarter 2019 total revenue of $8.2 million increased 9% year-over-year First half total revenue of $15.6 million increased 12% year-over-year Recurring revenue of $6.0 million increased 16% year-over-year Domestic installed base increased from 754 to 764 sequentially Gross margin
STRATA Skin Sciences to Participate in Canaccord Genuity 39th Annual Growth Conference
HORSHAM, Pa. , July 24, 2019 (GLOBE NEWSWIRE) -- STRATA Skin Sciences (NASDAQ: SSKN) (“STRATA”) a medical technology company in Dermatology and Plastic Surgery dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, today announced